Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06717750
What this trial is testing

CSCJC3456 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. 102
Testing effectiveness (Phase 2)WithdrawnNCT03868423
What this trial is testing

Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers

Who this might be right for
Advanced Malignant NeoplasmALK Fusion Protein ExpressionALK Gene Amplification+8 more
Sameek Roychowdhury
Testing effectiveness (Phase 2)Looking for participantsNCT06038396
What this trial is testing

RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
RemeGen Co., Ltd. 48
Testing effectiveness (Phase 2)Looking for participantsNCT07050641
What this trial is testing

Phase I/II Study of SCTB39-1 in Advanced Solid Tumours

Who this might be right for
Advanced Malignant Solid Tumor
Sinocelltech Ltd. 110
Testing effectiveness (Phase 2)Looking for participantsNCT04116541
What this trial is testing

A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.

Who this might be right for
Malignant Solid Tumor
Centre Leon Berard 455
Early research (Phase 1)Study completedNCT01473095
What this trial is testing

Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma

Who this might be right for
Solid TumorMalignant LymphomaTumor
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 120
Testing effectiveness (Phase 2)Looking for participantsNCT03907475
What this trial is testing

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
National Cancer Institute (NCI) 115
Early research (Phase 1)Looking for participantsNCT07190469
What this trial is testing

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC)Advanced Solid Tumors Cancer
ProteinQure Inc. 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07587879
What this trial is testing

Novel mRNA-LNP-Based Intratumoral Immunotherapy in Patients With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Solid Tumor
IntraAb, Inc. 60
Early research (Phase 1)Enrolling By InvitationNCT06115642
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Malignant Solid Tumors
Shanghai Henlius Biotech 367
Testing effectiveness (Phase 2)Study completedNCT04121442
What this trial is testing

Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors

Who this might be right for
Solid Tumor, Adult
Buzzard Pharmaceuticals 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02644369
What this trial is testing

Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Squamous Cell Cancer of Head and NeckTriple Negative Breast CancerEpithelial Ovarian Cancer+2 more
University Health Network, Toronto 100
Not applicableLooking for participantsNCT06658951
What this trial is testing

Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors

Who this might be right for
HER2-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc. 30
Early research (Phase 1)Study completedNCT05494918
What this trial is testing

First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid Tumors
Alphamab (Australia) Co Pty Ltd. 62
Early research (Phase 1)Study completedNCT04047290
What this trial is testing

AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors

Who this might be right for
Neoplasms Malignant
Akesobio Australia Pty Ltd 80
Early research (Phase 1)Study completedNCT01065025
What this trial is testing

Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies

Who this might be right for
Advanced and Incurable Solid TumorsMalignant Lymphomas
4SC AG 60
Early research (Phase 1)Looking for participantsNCT06171750
What this trial is testing

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCutaneous TumorSubcutaneous Tumor+6 more
Ankyra Therapeutics, Inc 97
Not applicableLooking for participantsNCT07752953
What this trial is testing

Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections for Malignant Solid Tumors

Who this might be right for
Advanced Solid TumorCancerMalignant Solid Tumor
ZSky Biotech Inc 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07774611
What this trial is testing

An Open-label Study of SG1827 Combined With Anti-PD-1/PD-L1 Antibody and Bevacizumab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Hangzhou Sumgen Biotech Co., Ltd. 180
Early research (Phase 1)Study completedNCT01165905
What this trial is testing

Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors

Who this might be right for
Solid Tumor
Traws Pharma, Inc. 10
Next Page